{"entity":{"type":"insider","cik":"0002034665","url":"/insider/0002034665","json_url":"/insider/0002034665.json","name":"Cohlhepp Ryan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":13,"first":"2025-10-08","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Cohlhepp Ryan","source":"filing","n_filings":13,"first_seen":"2025-10-08","last_seen":"2026-08-12"}],"transactions":[{"id":9289423,"accession":"0001470831-26-000812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000812","line_url":"/filing/0001470831-26-000812#line-1","is_derivative":false,"issuer_cik":"0002034665","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002034665","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18750.0,"shares_display":"18,750","price_per_share":27.9751,"price_display":"27.98","price_state":"stated","total_value":524533.125,"total_display":"524,533.12","total_whole":"524,533","shares_owned_after":181641.0,"shares_owned_after_display":"181,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":6054055,"accession":"0001470831-26-000701","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001470831-26-000701","line_url":"/filing/0001470831-26-000701#line-5","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":536.0,"shares_display":"536","price_per_share":29.0,"price_display":"29.00","price_state":"stated","total_value":15544.0,"total_display":"15,544.00","total_whole":"15,544","shares_owned_after":181641.0,"shares_owned_after_display":"181,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-09","filed_date":"2026-07-10","scope":"insider"},{"id":6054049,"accession":"0001470831-26-000701","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001470831-26-000701","line_url":"/filing/0001470831-26-000701","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28214.0,"shares_display":"28,214","price_per_share":28.978006939817114,"price_display":"28.98","price_state":"stated","total_value":817585.4878,"total_display":"817,585.49","total_whole":"817,585","shares_owned_after":187558.0,"shares_owned_after_display":"187,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-10","scope":"insider","n_lines":3},{"id":5896418,"accession":"0001628280-26-035937","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-035937","line_url":"/filing/0001628280-26-035937","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.2919,"price_display":"20.29","price_state":"stated","total_value":253648.75,"total_display":"253,648.75","total_whole":"253,649","shares_owned_after":196141.0,"shares_owned_after_display":"196,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-18","scope":"insider","n_lines":2},{"id":6219200,"accession":"0001628280-26-025817","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-025817","line_url":"/filing/0001628280-26-025817","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":23.0073,"price_display":"23.01","price_state":"stated","total_value":287591.25,"total_display":"287,591.25","total_whole":"287,591","shares_owned_after":200641.0,"shares_owned_after_display":"200,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider","n_lines":2},{"id":5896225,"accession":"0001628280-26-018934","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-018934","line_url":"/filing/0001628280-26-018934","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":19.6571,"price_display":"19.66","price_state":"stated","total_value":245713.75,"total_display":"245,713.75","total_whole":"245,714","shares_owned_after":205141.0,"shares_owned_after_display":"205,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-17","scope":"insider","n_lines":2},{"id":6055898,"accession":"0001628280-26-015423","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-015423","line_url":"/filing/0001628280-26-015423","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17392.0,"shares_display":"17,392","price_per_share":18.1631,"price_display":"18.16","price_state":"stated","total_value":315892.6352,"total_display":"315,892.64","total_whole":"315,893","shares_owned_after":209641.0,"shares_owned_after_display":"209,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-05","scope":"insider","n_lines":2},{"id":6172847,"accession":"0001628280-26-012823","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-26-012823","line_url":"/filing/0001628280-26-012823","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3631.0,"shares_display":"3,631","price_per_share":18.0395,"price_display":"18.04","price_state":"stated","total_value":65501.4245,"total_display":"65,501.42","total_whole":"65,501","shares_owned_after":210164.0,"shares_owned_after_display":"210,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-27","scope":"insider","n_lines":2},{"id":6187563,"accession":"0001628280-26-003419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-003419","line_url":"/filing/0001628280-26-003419#line-1","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3828.0,"shares_display":"3,828","price_per_share":18.1024,"price_display":"18.10","price_state":"stated","total_value":69295.9872,"total_display":"69,295.99","total_whole":"69,296","shares_owned_after":210164.0,"shares_owned_after_display":"210,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-22","filed_date":"2026-01-26","scope":"insider"},{"id":5741554,"accession":"0001628280-26-002656","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-002656","line_url":"/filing/0001628280-26-002656#line-1","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149.0,"shares_display":"149","price_per_share":18.02,"price_display":"18.02","price_state":"stated","total_value":2684.98,"total_display":"2,684.98","total_whole":"2,685","shares_owned_after":213992.0,"shares_owned_after_display":"213,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-20","scope":"insider"},{"id":4563903,"accession":"0002034665-25-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002034665-25-000011","line_url":"/filing/0002034665-25-000011","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.6838,"price_display":"18.68","price_state":"stated","total_value":233547.5,"total_display":"233,547.50","total_whole":"233,548","shares_owned_after":193641.0,"shares_owned_after_display":"193,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-16","scope":"insider","n_lines":2},{"id":5063326,"accession":"0002034665-25-000009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002034665-25-000009","line_url":"/filing/0002034665-25-000009","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.047,"price_display":"18.05","price_state":"stated","total_value":225587.5,"total_display":"225,587.50","total_whole":"225,588","shares_owned_after":198141.0,"shares_owned_after_display":"198,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-21","filed_date":"2025-11-25","scope":"insider","n_lines":2},{"id":4078842,"accession":"0002034665-25-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002034665-25-000006","line_url":"/filing/0002034665-25-000006","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":18.1554,"price_display":"18.16","price_state":"stated","total_value":226942.5,"total_display":"226,942.50","total_whole":"226,943","shares_owned_after":202641.0,"shares_owned_after_display":"202,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-16","scope":"insider","n_lines":2},{"id":4781139,"accession":"0002034665-25-000004","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0002034665-25-000004","line_url":"/filing/0002034665-25-000004","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10900.0,"shares_display":"10,900","price_per_share":18.0591,"price_display":"18.06","price_state":"stated","total_value":196844.19,"total_display":"196,844.19","total_whole":"196,844","shares_owned_after":205541.0,"shares_owned_after_display":"205,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-07","filed_date":"2025-10-08","scope":"insider","n_lines":2},{"id":4781127,"accession":"0002034665-25-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0002034665-25-000004","line_url":"/filing/0002034665-25-000004","is_derivative":false,"issuer_cik":"0002023658","issuer_name":"Bicara Therapeutics Inc.","issuer_ticker":"BCAX","issuer_name_source":null,"issuer_url":"/issuer/0002023658","owner_cik":"0002034665","owner_name":"Cohlhepp Ryan","owner_display_name":"Cohlhepp Ryan","owner_url":"/insider/0002034665","role":"Director, Officer (President and COO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39600.0,"shares_display":"39,600","price_per_share":18.0555,"price_display":"18.06","price_state":"stated","total_value":714997.8,"total_display":"714,997.80","total_whole":"714,998","shares_owned_after":221141.0,"shares_owned_after_display":"221,141","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-06","filed_date":"2025-10-08","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":27,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002023658","name":"Bicara Therapeutics Inc.","url":"/issuer/0002023658","role":"Director, Officer (President and COO)","n_filings":13,"first_seen":"2025-10-08","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002034665","retrieved_at":"2026-08-23T19:00:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}